Sunshine Biopharma SBFM Q2 2026 earnings

FAQ

When did Sunshine Biopharma report Q2 2026 earnings?

Sunshine Biopharma (SBFM) reported Q2 2026 earnings on August 13, 2026 before market open.

What were Sunshine Biopharma's Q2 2026 revenue and EPS?

Sunshine Biopharma reported revenue of $9.3M and eps of $-1.15 for Q2 2026.

Did Sunshine Biopharma beat estimates in Q2 2026?

Revenue beat the consensus estimate of $8.7M by $563.7K. EPS beat the consensus estimate of $-1.20 by $0.05.

How did Sunshine Biopharma's Q2 2026 results compare year-over-year?

Compared to the same quarter a year prior, revenue declined 1.6% from $9.4M a year earlier and eps declined 194.9% from $-0.39.

Where can I find Sunshine Biopharma's Q2 2026 SEC filings?

You can read the 10-Q periodic report (0001683168-26-006340) directly on SEC EDGAR. The filing index links above go to sec.gov.